Jon Snodgres, Chief Financial Officer at REPLIGEN CORP (RGEN), sold 12,934 shares at $59.05 ($757K) on 2019-03-25, disclosed to the SEC on 2019-03-27.
Seasonal sale ($757k) by Chief Financial Officer — this insider has traded RGEN in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.45 | 5,458 | $319K | 42.1% |
| 2 | $58.45 | 5,458 | $319K | 42.1% |
| 3 | $59.05 | 1,009 | $60K | 7.9% |
| 4 | $59.05 | 1,009 | $60K | 7.9% |
| Total | $58.54 avg | 12,934 | $757K | 100% |
| Filing → |
| RGEN | SELL | 2022-08-02 | $440K | — | Filing → |
| RGEN | SELL | 2021-05-18 | $81K | — | Filing → |
| RGEN | SELL | 2021-03-08 | $797K | — | Filing → |